4
Changes in Ownership
Werewolf Therapeutics, Inc. Filed Acc 0001785530-21-000047
Options or other derivatives
- Director acquired 23,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Chatterjee Meeta Director | 2021-10-28 | Grant or award · Stock Option (right to buy) | +23,200 | 23,200 | D | ||
Loading xslF345X03/wf-form4_163579752074123.xml…